Home2L9 • FRA
add
Blueprint Medicines Corp
Previous close
€76.52
Day range
€87.10 - €87.10
Year range
€67.54 - €111.00
Market cap
6.76B USD
Avg Volume
11.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 149.41M | 55.45% |
Operating expense | 187.70M | 9.29% |
Net income | 496.00K | -99.44% |
Net profit margin | 0.33 | -99.64% |
Earnings per share | -0.29 | 77.75% |
EBITDA | -36.63M | 50.51% |
Effective tax rate | 61.40% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 576.24M | -11.06% |
Total assets | 1.20B | 15.13% |
Total liabilities | 853.47M | 17.27% |
Total equity | 342.13M | — |
Shares outstanding | 64.58M | — |
Price to book | 14.44 | — |
Return on assets | -8.65% | — |
Return on capital | -9.88% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 496.00K | -99.44% |
Cash from operations | -54.48M | 46.33% |
Cash from investing | 65.08M | -15.63% |
Cash from financing | 9.19M | -86.27% |
Net change in cash | 20.45M | -51.80% |
Free cash flow | -20.51M | 72.92% |
About
Founded
2008
Website
Employees
682
